
FDA Approves New Blood Tests for Alzheimer’s Detection
The FDA has approved multiple blood tests for detecting Alzheimer's disease, including Roche and Eli Lilly's Elecsys pTau217 test and C2N Diagnostics' PrecivityAD2. These tests measure proteins linked to brain amyloid and tau, enabling earlier detection and more accessible evaluation of the disease.14 sourcesSee all sources
